VC investor specialising in early stage high-growth deep tech companies in the life science, sustainability and industrials sectors
EMV Capital is an award-winning VC investor specialising in early stage high-growth deep tech companies in the life science, sustainability and industrials sectors in the UK and internationally. EMV Capital develops unique investment strategies for each portfolio company, drawing on its EIS fund and extensive network of private investors, family offices, institutions, and corporate VCs. Delivery and successful execution of these investment strategies enables innovative portfolio companies to raise funding to drive transformational growth.EMV Capital is a wholly owned subsidiary of NetScientific plc (AIM:NSCI), a life sciences and technology commercialisation and investment group. EMV Capital has a multi-disciplinary team of specialist investors, portfolio managers, capital raisers, legal, finance, marketing and support staff. The company is focused on primary and secondary investments, through debt and/or equity.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 22, 2019
Vortex Biosciences
|
Series A | — | Biotechnology | Yes |
May 2, 2018
Nanotech Industrial Solutions
|
Series Unknown | $12M | Electronics | Yes |
EMV Capital has acquired 1 organizations. Their most recent acquisition was Vortex Biosciences on Apr 25, 2019. They acquired Vortex Biosciences for 0.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Apr 25, 2019
Vortex Biosciences
|
Biotechnology | acquisition | — | Detail |